Skip to main content
. Author manuscript; available in PMC: 2008 Aug 6.
Published in final edited form as: Anesth Analg. 2008 Aug;107(2):525–533. doi: 10.1213/ane.0b013e31817b4469

Fig. 3.

Fig. 3

Our approach to determining the isobologram for combination of (+)-tubocurarine and pancuronium. (A) The concentration-response curve of (+)-tubocurarine alone. The solid line is the fit to Equation 1; the gray lines are ±1 SD of the fit. The dashed line indicates the IC90. (B) The concentration-response curve of pancuronium alone. (C) The concentration-response curve of (+)-tubocurarine in the presence of 15 nM pancuronium. (D) The isobologram of the combination of (+)-tubocurarine and pancuronium. The solid squares indicate the IC90 values of each antagonist alone and provide the endpoints for the line of additivity. The open square is drawn at [pancuronium]=15 nM and [(+)-tubocurarine]= its IC90 determined in the presence of 15 nM pancuronium. The dashed curve is an isobologram assuming that the antagonists bind exclusively to different sites.